Schwazze Snaps Up Everest Apothecary in New Mexico for $38 Million

April 25, 2023 · Green Market Report

Schwazze will now own 32 dispensaries between Everest Apothecary and R. Greenleaf.

Denver-based Medicine Man Technologies Inc., which operates as Schwazze (OTCQX: SHWZ) (NEO: SHWZ), has signed definitive documents to acquire a batch of cannabis assets in New Mexico.

The acquisition will allow Schwazze to manage Everest Apothecary, a non-profit corporation operating in the state. The proposed transaction includes 14 retail dispensaries, a cultivation facility, and a manufacturing plant.

Upon completion of the acquisition, Schwazze will have a total of 32 dispensaries in New Mexico, with over 450 employees.

The purchase price for the proposed acquisition is $38 million. Schwazze will pay the sum using a combination of cash, a four-year seller note, and company common stock. The acquisition is expected to close in the second quarter of 2023, subject to approval from the New Mexico Regulation and Licensing Department.

“This planned acquisition shows our commitment to the Company’s super-regional cannabis growth strategy to go deep in select markets,” Schwazze president Nirup Krishnamurthy said in a statement.

“The Everest brand is a perfect complement to our existing retail brand in New Mexico. Each serves a unique demographic, and we will continue to operate both retail banners in the state.”

Krishnamurthy added that by utilizing Schwazze’s operating playbook, the company intends to support the Everest team and its customers under the new deal.

Once commonly known as Medicine Man, Schwazze’s aggressive expansion strategy began in April 2020, after the company went public and has since snapped up retail competitors around Colorado and New Mexico, as well as eight cultivation facilities and three manufacturing plants.

The company also recently announced its biosciences division and commenced home delivery services in Colorado. It plans to continue pursuing acquisitions, partnerships, and strategic investments to expand its retail presence and market share.

Schwazze posted an annual $18.5 million loss by the end of 2022, in part due to its acquisitions and entry in New Mexico. Still, the company posted solid increases in revenue, profit, retail sales, and cash flow for both the full year and for the fourth quarter. (Full Story)

Next Post

Here’s what weed tourists from Texas can expect to find inside recreational pot shops

Marijuana is still an illegal substance in Texas. But with neighboring states offering recreational weed, many Texans are crossing state lines to taste the high life. In total, 21 states across the U.S. have legalized recreational marijuana use — Colorado and…
Previous Post

Data Confirms 4/20 is THE High Holiday

Sales on 4/20 were roughly twice the sales of a typical Thursday. Now that 4/20 is officially in the rearview mirror, the bean counters say that this year’s holiday did not disappoint. Consumers clearly don’t care whether cannabis companies are…
Random Post

Dodgy science, poor access and high prices: The parallel medical world of medicinal marijuana in America

BURTON, Mich. — Before Jayden Carter turned 9, police were called 126 times to his school, home and other locations to address his violent behavior. “I had ribs out of place, my forehead cut open, black eye,” recalled Amie Carter,…
Random Post

Is The Cannabis Industry Leading The Next American Industrial Revolution? You Bet.

Many have touted the health and tax revenue benefits cannabis can bestow. But little has been said about how the cannabis industry is leading the next industrialized revolution by building a new sector to manufacture cannabis products for a global…
Random Post

Red States' Anti-Pot Laws Start to Crack? - Is Missouri the First Domino of Red States about to Approve Recreational Marijuana?

Missouri is poised to become the latest state in the U.S. to launch recreational cannabis sales. The move will likely attract the attention of marijuana businesses and voters in nearby Oklahoma, who will vote next month on whether to legalize adult…
Random Post

European cannabis execs would welcome German trial legalization program

European cannabis executives would welcome a decision by the German government to pursue a trial recreational cannabis program versus nationwide legalization – even if that meant a significantly smaller market for businesses to pursue. Still, some experts say any trial…